Tacrogral tacrolimus medication

Tacrogral is a pharmaceutical product containing the active ingredient tacrolimus, an immunosuppressant primarily used to prevent organ rejection in patients receiving transplants, such as kidney, liver, or heart transplants. The brand is specifically associated with the Argentine pharmaceutical market and is used to maintain stable drug levels in the bloodstream.

The brand was developed and is owned by Laboratorios Bagó, a major Argentine multinational company. Manufacturing primarily takes place in Argentina, where the company operates several high-tech pharmaceutical production facilities. Bagó is one of the most prominent healthcare companies in Latin America, focusing on a wide range of therapeutic areas including cardiology, gastroenterology, and specialty medicines like transplant care.